Company Overview of Origen Therapeutics, Inc.
Origen Therapeutics, Inc., a biotechnology company, develops products from avian transgenic animal technology. It provides human sequence polyclonal antibodies. The company also develops a technology platform based on the genetic engineering of chicken embryonic cells, which can be genetically modified in such a way that the introduced genes are stably expressed in adult birds. Origen Therapeutics, Inc. was incorporated in 1997 and is based in Emeryville, California.
5885 Hollis Street
Emeryville, CA 94608
Founded in 1997
Key Executives for Origen Therapeutics, Inc.
Similar Private Companies By Industry
|Synbody Biotechnology, Inc.||United States|
|Bridge to Life, Ltd.||United States|
|AMPRO Products, Inc.||United States|
|Rozetta-Cell Life Sciences, Inc.||United States|
|QT Holdings Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Origen Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.